Clients in the Media Found 2 Results May 27, 2025 | AP Biosciences AP Bio heads to phase I with bispecific for HER2-resistant tumors BioWorld February 25, 2025 | MeiraGTx Meiragtx’s gene therapy shows exceptional data for blind children BioWorld